NEW YORK, NY / ACCESSWIRE/ November 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Roadrunner Transportation Systems Inc. (NYSE: RRTS), Varonis Systems Inc. (NASDAQ: VRNS), Glu Mobile Inc. (NASDAQ: GLUU) and Cytokinetics Inc. (NASDAQ: CYTK). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
RRTS Research Package: http://www.traders-choice.com/pdf?s=RRTS
VRNS Research Package: http://www.traders-choice.com/pdf?s=VRNS
GLUU Research Package: http://www.traders-choice.com/pdf?s=GLUU
CYTK Research Package: http://www.traders-choice.com/pdf?s=CYTK
============
Highlights from today's reports include:
On Monday, November 09, 2015, NASDAQ ended at 5,095.30 down 1.01%, Dow Jones declined 1.00%, to finish the day at 17,730.48, and the S&P closed at 2,078.58, down 0.98%.
- Roadrunner Transportation Systems Inc.'s stock slipped by 0.36% to close Monday's session at USD 11.00, much below its 50-day and 200-day moving average of USD 17.60 and USD 23.26, respectively. The company's shares oscillated between USD 10.80 and USD 11.09. The stock recorded a trading volume of 0.39 million shares, which was above its 52-week average volume of 0.24 million shares. Over the last five days, Roadrunner Transportation Systems Inc.'s shares have declined by 3.25% and in the past one month, it has lost 41.11%. In addition, over the last three months, the stock has lost 55.28% and year to date, the shares have shed 52.89%. Further, the company is trading at a price to earnings ratio of 7.53 and at a price to book ratio of 0.71. This compares to a historical PE ratio of 17.64. The historical PB ratio is near to 1.58. Additionally, the stock is trading at a price to cash flow ratio of 4.22.
- Varonis Systems Inc. stock declined 1.12% to end the session at USD 16.74, below its 50-day and 200-day moving average of USD 17.03 and USD 23.24, respectively. The share price oscillated between USD 16.19 and USD 17.18. The stock recorded a trading volume of 0.22 million shares, which was above its 50-day daily average volume of 0.19 million shares. Over the last three days, Varonis Systems Inc.'s shares have declined by 1.99% while in the past one week it has moved up 1.33%. In the last six months, the stock has lost 14.20% and year to date, the shares have shed 49.01%. On a compounded total return basis, the company has returned 3.65% in the past one month. Further, the company is trading at a price to book ratio of 5.2. The price to sales ratio stood at 3.8. Varonis Systems Inc. has a market cap of USD 417.2 million.
- Glu Mobile Inc.'s stock edged lower by 2.95% to finish Monday's session at USD 3.13, below its 50-day and 200-day moving average of USD 4.27 and USD 5.25, respectively. The company's shares oscillated between USD 3.09 and USD 3.16. The stock recorded a trading volume of 3.70 million shares, which was above its 50-day daily average volume of 2.46 million shares and above its 52-week average volume of 2.90 million shares. Over the last three days, Glu Mobile Inc.'s shares have declined by 15.99% and in the past one week it has moved down 15.08%. Furthermore, over the last three months, the stock has lost 33.37% and in the past six months, the shares have shed 53.50%. The company is trading at a price to earnings ratio of 38.40 and at a price to book ratio of 1.40. This compares to a historical PE ratio of 46.39. The historical PB ratio is near to 2.43.
- The stock of Cytokinetics Inc. gained 13.59% to close Monday's session at USD 12.29, above its 50-day and 200-day moving average of USD 7.58 and USD 7.02, respectively. The shares of the company moved in the range of USD 11.14 and USD 12.50. A trading volume of 1.89 million shares was recorded, which was greater than its 150-day daily average volume of 0.39 million shares and above its 52-week average volume of 0.43 million shares. Over the last five days, Cytokinetics Inc.'s shares have advanced 18.97% and in the past one month, it has gained a momentum of 76.07%. Additionally, over the last three months, the stock has advanced 78.12% and in the past six months, the shares have registered a profit of 84.81%. The company has returned 79.68% in the last three months, on a compounded total return basis. Further, the stock is trading at a price to sales ratio of 10.34.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
